NEW YORK, Dec. 1 Reportlinker.com announces that a new market research report is available in its catalogue:
Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities
Advertisement
http://www.reportlinker.com/p0164526/Contract-Research-Outsourcing-CRO---A-Global-Update-of-Market-Trends--Opportunities.html
Contract Research Outsourcing (CRO), which came into being in the seventies, evolved into an essential component of pharmaceutical market scenario. CRO has emerged as a topic of great interest in the global pharmaceutical and biotechnology markets. Patent expiries, heightened competition in generic drug space, and dwindling drug discoveries necessitate research and development (R&D), innovation, and marketing of new pharma and biotech products to combat price fixing and cost escalations. Smaller product life spans, worldwide regulatory challenges, and the increasingly slim deadlines for clinical development magnify in-house R&D expenditure and affect productivity. The CRO concept emerged as a means to control in-house R&D costs, expand capacities, and improve core skills. Contract research organizations now offer a whole array of expert services ranging from pharmacology, pre-clinical safety evaluation, clinical trial management, study design, statistical analysis, regulatory services, and data collection to product support.
Advertisement
These and other market data and trends are presented in "Contract Research Outsourcing: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
CONTRACT RESEARCH OUTSOURCING (CRO) BMR-6003
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. INDUSTRY OVERVIEW 4
Background 4
Growth and Transformation of CRO Industry 4
Advantages of CRO for Pharma and Biotech Companies 5
Advantages of CRO for Clinical Research Organizations 5
3. INDUSTRY POTENTIAL 5
Outlook 5
Competition Potential 6
Regional Potential 9
The United States 9
Western Europe 9
Central and Eastern Europe 9
Asia-Pacific 10
China 10
India 10
Latin America 10
Service Potential 10
Pre-Clinical Segment Gains Momentum 11
Clinical Research - Encouraging Factors at Various Phases 11
Phase I 11
Phase II 11
Phase III 11
Phase IV 12
Research & Development Potential 12
4. MARKET DYNAMICS 13
Challenges Faced by Contract Research Organizations 13
On-shore versus Offshore CRO Business 13
Cutthroat Competition Among CROs 13
Management of Production Capacities 14
Management of Clinical Investigation 14
Cost Containment 14
Safety Concerns on Clinical Trials 14
Pipeline Blocks 14
Strategies and Tactical Programs for CROs 14
Survival Strategies in Mature CRO Markets 15
Exit from the Industry 15
Expand Scale 15
Capture Niche Segments 15
Expand Geographically 15
Strategies to Tap Opportunities in Growing Markets 15
Mobilize Funds 15
Expand Other Services 16
Upgrade Technological and Knowledge Base 16
Form Sub-Contracts or Regional Alliances 16
Asia - Hub for Contract Research Outsourcing 16
Overview 16
Market Potential 16
Activity Perspective 17
Cost-Efficiency in Research and Development 17
World-Class Clinical Trials 17
Regional Perspective 17
China 17
Congenial Business Environment 17
Compliance with Global CRO Standards 18
Return of Skilled Human Resources 18
Availability of Large Genetic Population 18
Cost Advantages 18
India 18
Large Talent Pool of Human Resources 18
Increased Regulatory Compliance 18
Rich Genetic Diversity 19
Cost-Savings and World-Class Quality 19
Challenges in Outsourcing 19
China 19
Regulatory Hurdles 19
Limited Funding Resources 20
Demand War for Talented Personnel 20
Teething problems 20
Cultural and Language Difficulties 20
India 20
Restrictions on Clinical Trials 20
Lack of Standardization 20
Advantage India - hot spot for R&D investment 20
Subject-compliance in major therapeutic areas 20
Reliable Data Generation and Management 21
Improved Base of Medical Infrastructure 21
Strong Combination of CMOs and CROs 21
Reverse-engineering Capabilities 21
Market Trends 21
Biotech Leads in CRO 22
5. CORPORATE DEVELOPMENTS 22
Symyx Takes Over Integrity Biosolution 22
Worldwide Clinical Trials Acquires MediQuest 23
BioImagene Launches a New CRO, AgilityBio 23
Tigermed Receives Investments from Qiming 23
Covance Inks MoU with WuXi for a Chinese Joint Venture 23
Veeda Takes Over International Oncology Network 24
Kendle Acquires DecisionLine 24
Encorium to Take Over Prologue Research 24
PharmaLinkFHI Takes Over Matrix Contract Research Ltd. 24
Encorium Receives Business Contracts for North America and Europe 25
India's Jubilant Organosys to Takeover Draxis Health 25
Shasun to Establish Process Development Unit in US 25
Quintiles to Open Second Clinical Research Office in Wilmington 26
LabCorp to Acquire Tandem Labs 26
Shasun to Establish Process Development Unit in US 26
MDS Pharma Expands in Latin America 26
Iris Pharma and Clirophtha Merge to form New Iris Pharma 27
PPD to Acquire InnoPharm 27
KCR Acquires DUX Consuling 27
Cetero Research Acquires DGD Research 27
Jubilant Organosys Acquires Hollister-Stier Laboratories 27
Shasun Acquires Rhodia Pharma Plants 28
Ocimum Biosolutions Acquires Gene Logic's Genomics Business 28
Innovative Medical Device Sourcing Acquires Frontier
BioMedical LLC 28
UK-Based Premier Research Group PLC Acquires ARS, Inc. 28
AAIPharma, Inc. Acquires Instituto de Pesquisa Clinica de Sao
Paulo Ltda 28
Covance to Renovate New Drug Development Facility in Virginia 29
Covance Expands and Reshuffles Research Clinic 29
Perceptive Informatics Alliance To Enhance Clinical Supply
Chain Forecasting and Management 29
Genstar Capital Acquires PRA International 29
Covalent Acquires Remedium Oy and Changes Name to Encorium 30
Quintiles Enters Into a New Alliance with Washington County
Hospital 30
Kendle Expands in US and Europe 30
Criterium Opens Two New Offices in Russia and Israel 30
Premier Research Acquires Two Companies to Expand Product
Offerings 30
Averion Divests Staffing Services Segment 30
Chiltern Acquires CTMS 31
Quintiles Acquires Bio-Trials 31
Parexel Acquires Apex International Clinical Research 31
Charles River Forms Joint Venture with BioExplorer 31
PAREXEL Opens New Location In India 31
Avesthagen and Manipal Accunova Collaborate 32
Matrix and ethica Clinical Research form ethicamatrix 32
Covance Opens Nutritional Chemistry Laboratory in Singapore 32
MDS Pharma to Expand in European Market 32
Vita Nova Acquires Sedoc 33
Averion Acquires Hesperion 33
Averion and BIOCANCER Form Strategic Alliance 33
AstraZeneca Opens First CPU to Enhance Clinical Research in China 33
AstraZeneca Acquires Biologics Manufacturing Facility 33
AstraZeneca Inaugurates Global Process R&D Lab in Bangalore 33
6. MAJOR PLAYERS 34
Contract Research Organizations 34
Criterium, Inc. (US) 34
Covance, Inc. (US) 34
Encorium Group, Inc. (US) 34
ICON PLC (Ireland) 34
Kendle (US) 34
Life Sciences Research, Inc. (US) 35
MDS Pharma Services (US) 35
MPI Research (US) 35
Omnicare Clinical Research (US) 35
Parexel International Corporation (US) 35
PharmaNet Development Group, Inc. (US) 36
PRA International (US) 36
Pharmaceutical Product Development, Inc. (US) 36
Quintiles Transnational Corporation (US) 36
WIL Research Laboratories, LLC (US) 36
Preclinical Laboratories 37
Bio Analytical Research Corporation (US) 37
Calvert Laboratories, Inc. (US) 37
CentraLabS Clinical Research (US) 37
Charles River Laboratories, Inc. (US) 37
Huntingdon Life Sciences Research, Inc. (UK) 37
Laboratory Corporation of AmericaŽ Holdings (US) 38
Lab Research, Inc. (Canada) 38
Pacific Biometrics, Inc. (US) 38
Perry Scientific, Inc. (US) 38
Quest Diagnostics, Inc. (US) 38
SNBL USA, Ltd. (US) 39
Site Management Organizations 39
DaVita Clinical Research (US) 39
nTouch Research Corporation (US) 39
PharmaTrials, Inc. (US) 39
Radiant Research, Inc. (US) 40
Research Solutions, LLC (US) 40
7. MARKET ANALYTICS 40
8. THE UNITED STATES 42
Market Overview 42
Competitive Scenario 43
9. EUROPE 44
Market Overview and Outlook 44
Competitive Scenario 44
Eastern Europe - Center for Clinical Trials 44
10. ASIA 46
Promising Market 46
Outsourcing Destinations: China and India 46
Promoting Role of the Government 47
Focus on Key Markets 47
India 47
A Thriving Clinical Trial Market 47
Reasons for Outsourcing to India 48
List of Pharmaceutical Companies Outsourcing Clinical
Research to India 49
SWOT Analysis 49
Competitive Scenario 50
Regulatory Environment 50
China 50
Factors Favoring Outsourcing Activity 50
SWOT Analysis 51
Policies Governing Clinical Trials 51
Clinical Research Market Size 51
11. REST OF WORLD 53
EXHIBITS
Table 1: Percentage Breakdown of Pipeline Drugs by Phase in
the World - 2007
Table 2: Percentage Breakup of Life Sciences Revenues of Major
Players by Service Type - 2007
Table 3: Number of CROs by Service Type in the World - 2007
Table 4: Market Shares of Pre-clinical CRO Providers in the
World - 2007
Table 5: Leading Biotechnology and Pharmaceutical Research
Companies Worldwide - Ranked by Year 2006 Revenues in US$
Million
Table 6: Percentage Breakup of Global R&D Spending by Region
(2008E)
Table 7: Percentage Breakup of Global R&D Spending by Market
(2007-2010)
Table 8: Cost of Conducting Clinical Trials: India Vs US (In
US$ Million)
Table 9: Global Contract Research Outsourcing by Region for
the Period 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown of Global Contract Research
Outsourcing by Region for the Years 2008 & 2012
Table 11: Global Contract Research Outsourcing for Drug
Discovery by Region for the Period 2007-2015 (Sales in US$
Million)
Table 12: Percentage Breakdown of Global Contract Research
Outsourcing for Drug Discovery by Region for the Years 2008 &
2012
Table 13: Global Contract Research Outsourcing for Clinical
Research by Region for the Period 2007-2015 (Sales in US$
Million)
Table 14: Percentage Breakdown of Global Contract Research
Outsourcing for Clinical Research by Region for the Years 2008 &
2012
Table 15: Percentage Breakdown of CRO Revenues by Player
Category - 2007
Table 16: Contract Research Outsourcing by Service Segment in
the US: 2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Contract Research
Outsourcing by Service Segment in the US for the Years 2008 &
2012
Table 18: Contract Research Outsourcing by Service Segment in
Europe: 2007-2015 (Sales in US$ Million)
Table 19: Percentage Breakdown of Contract Research
Outsourcing by Service Segment in Europe for the Years 2008 &
2012
Table 20: CRO Market Size (US$ million) for Clinical Research
in Asia (2007-08)
Table 21: Indian CRO Market Revenues in US$ Million
(2007-2010)
Table 22: CRO Market Size (US$ million) for Clinical Research
in China (2007-08)
Table 23: Percentage Breakdown of Japanese CRO Value Sales by
Segment - 2007
Table 24: Contract Research Outsourcing by Service Segment in
Asia: 2007-2015 (Sales in US$ Million)
Table 25: Percentage Breakdown of Contract Research
Outsourcing by Service Segment in Asia for the Years 2008 &
2012
Table 26: Contract Research Outsourcing by Service Segment in
Rest of World: 2007-2015 (Sales in US$ Million)
Table 27: Percentage Breakdown of Contract Research
Outsourcing by Service Segment in Rest of World for the Years
2008 & 2012
COMPANIES PROFILED
To order this report:
Business Outsourcing Industry: Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities
More Market Research Report
Nicolas BombourgReportlinkerEmail: [email protected]: (805)-652-2626Intl: +1 805-652-2626
SOURCE Reportlinker